25-Mar-2015 - The European Commission has published guidelines on GMP excipients after a two-year consultation.
25-Mar-2015 - AbbVie is investing $30m (€27m) in contract manufacturing facilities in Puerto Rico and plans to create 100 jobs over the next two years.
17-Mar-2015 - The European pharma market isn’t likely to deliver much growth over the next five years as generic markets commoditize, IMS Health VP Graham Lewis warned participants at the DCAT (Drug, Chemical and Associated Technologies) conference on Monday.
11-Mar-2015 - Penn Pharma has added new tablet making technology at its facility in Tredegar, Wales citing drug industry demand for dry granulation manufacturing capacity.
11-Mar-2015 - API- and catalyst-maker Johnson Matthey has built high containment facilities for potent products at its site in Edinburgh, Scotland.
03-Mar-2015 - Indian giant Sun Pharma has bought GSK’s Australian Opiates business.
26-Feb-2015 - A new California bill introduced earlier this week would, for the first time, require pharma companies to unveil a number of unique operational costs as a way to better understand drug pricing.
24-Feb-2015 - In order to close Novartis’ $16bn purchase of GlaxoSmithKline’s portfolio of cancer treatments , the FTC (Federal Trade Commission) is requiring Novartis to divest all assets related to its potential BRAF and MEK inhibitor drugs to settle anticompetitive charge.
17-Feb-2015 - Fresenius Kabi has sold its cancer drug pharmacy network CFL GmbH to NewCo Pharma GmbH five years after spending €42m to buy compounding capacity in Germany.
16-Feb-2015 - Quick question for chemists: Have you ever wanted to research chemical reactions and buy catalysts on your mobile phone?
11-Feb-2015 - Gilead Sciences has committed S20m (€18m) to expand its presence in the UK and will double its workforce in the country.
11-Feb-2015 - In a wide-ranging interview that included his take on competition from Google and R&D spending, Pfizer CEO Ian Read offered a number of clues as to where his company is headed.
09-Feb-2015 - Pfizer visited three troubled facilities in Hospira’s manufacturing network before entering a $17bn definitive merger agreement, the company says.
29-Jan-2015 - Novartis has divested, restructured, or mothballed 24 manufacturing plants since 2010 but says its new NBS cost-saving business will not focus on streamlining and consolidating sites.
27-Jan-2015 - A human hair found in a vial of Sodium Chloride Injection has led to the fortieth recall in three years for Hospira.
26-Jan-2015 - A morning sickness drug made by Duchesnay USA will now display Halal and Kosher symbols – a move the company said is the first case of Kosher certification for an oral prescription drug in the US.
21-Jan-2015 - Teva must invest in its biomanufacturing network as the firm’s biologics aspirations grow beyond biosimilars, CEO Erez Vigodman told investors.
19-Jan-2015 - Hospira has announced it will close its plant in Clayton, North Carolina that it no longer deems cost effective for drug production.
19-Jan-2015 - Novartis will close an OTC plant in Puerto Rico by 2019 and transfer manufacturing and packaging actives to sites in the US and facilities operated by Eli Lilly and Virbac.
19-Jan-2015 - EFPIA has given J&J subsidiary Crucell Holland and partner Bavarian Nordic €47.6m ($54.9m) to accelerate development of an candidate Ebola vaccine.
15-Jan-2015 - A Fresenius Kabi plant in New York has been upgraded, and up to five new products could receive FDA approval, almost three years after receiving a warning letter.
15-Jan-2015 - AstraZeneca and Baxter are opting to transport pharmaceuticals by ocean and land routes as costs and cold chain security drive a drop in air freight.
14-Jan-2015 - Critical solvents used by the pharmaceutical manufacturers have been excluded from the EPA's final ruling on waste disposal, in a move welcomed by a US industry group.
13-Jan-2015 - Fareva has added extra micronization capacity citing growing demand and the opportunity to work with customers earlier in the development process as the driver for the investment.
12-Jan-2015 - Almost two years since it was first rejected , Impax Pharmaceuticals said late last week that the US FDA has approved Rytary, an extended-release oral capsule formulation of carbidopa-levodopa, for the treatment of Parkinson's disease.
Dispatches from DCAT
The European pharma market isn’t likely to deliver much growth over the next five years as generic...
More drugs for tropical diseases have been donated since the London declaration of 2012, but getting them...
The FDA has tested hundreds of creatively named bogus supplements and found they contain hidden APIs. Take...